ARCHIVES

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

This article is from The Cancer Letter archive.

Vol. 13 No. 36 | September 18, 1987

Download PDF Visit The Full Archive

Related Articles

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

Brown Disagrees With Staff, Subgroup On Dichlorvos, Says It Is a Carcinogen

September 2, 1977

Physician Bonus Denied Some Agencies; NIH Status Unsure

January 18, 1991

PI Defends NCI’s National Lung Screening Trial As “Rigorous” Randomized Trial.

November 3, 2006

Funding Opportunites: Society to Fund Grants In Women’s Health Research

January 22, 1999

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

October 20, 2000